Comparison of the Inflammatory Burden of Truly Asymptomatic Carotid Atheroma with Atherosclerotic Plaques in Patients with Asymptomatic Carotid Stenosis Undergoing Coronary Artery Bypass Grafting: An Ultrasmall Superparamagnetic Iron Oxide Enhanced Magnetic Resonance Study
T.Y. Tang,S.P.S. Howarth,S.R. Miller,M.J. Graves,J.M. U-King-Im,Z.Y. Li,S.R. Walsh,P.D. Hayes,K. Varty,J.H. Gillard
DOI: https://doi.org/10.1016/j.ejvs.2007.10.019
IF: 6.427
2008-01-01
European Journal of Vascular and Endovascular Surgery
Abstract:Results The mean percentage of quadrants showing signal loss was 94% in the CABG group, compared to 24% in the completely asymptomatic individuals ( p < 0.001). The carotid plaques from the CABG patients showed a significant mean signal intensity decrease of 16.4% after USPIO infusion (95% CI 10.6% to 22.2%; p < 0.001). The truly asymptomatic plaques showed a mean signal intensity increase (i.e. enhancement) after USPIO infusion of 8.4% (95% CI 2.6% to 14.2%; p = 0.007). The mean signal difference between the two groups was 24.9% (95% CI 16.7% to 33.0%; p < 0.001). Conclusions These findings are consistent with the hypothesis that inflammatory atheroma is a systemic disease. The carotid territory is more likely to take up USPIO if another vascular territory is symptomatic. Keywords Carotid stenosis Atherosclerosis USPIO MRI Inflammation Plaque vulnerability CABG Search Terms MRI [120] Stroke prevention [12] Other cerebrovascular disease/stroke [13] Introduction Plaque inflammation and macrophage infiltration are important predictors of plaque rupture and embolic events. 1 Advances in the understanding of plaque biology and the shortcomings of angiography have stimulated the development of novel imaging techniques to identify and quantify inflammation within carotid disease. It has been possible to image carotid plaque inflammation with Ultra small Super-Paramagnetic Iron Oxide (USPIO) enhanced MR imaging in humans. 2 The use of a USPIO agent – Sinerem™ (Guerbet, France), has allowed the direct visualisation of macrophage infiltration of carotid atheroma in-vivo. 2–4 USPIO particles are taken up by activated macrophages in vulnerable plaques and when clumped in phagolysosomes produce a T 2 * susceptibility effect, visible on as signal voids ( Fig. 1 ). In contrast, there is a predominant T 1 shortening effect at low concentrations of USPIO in tissue, allowing potentially better visualisation of the fibrous cap and suggesting that this contrast agent could be used to detect not only inflammation within vulnerable plaque but also aid in identification of “safer” plaque with a significant fibrous component. 5 Whilst USPIO imaging relies on a decrease in signal intensity due to a T 2 * susceptibility effect, signal enhancement is predominantly a T 1 shortening phenomenon and may be related to decreased USPIO concentration within tissue and may well be unrelated to macrophage density although further work is required to determine this relationship more fully. Currently, there is no consensus on the management of the asymptomatic carotid stenosis in patients undergoing coronary artery bypass grafting (CABG). The efficacy of carotid endarterectomy (CEA) before or combined with CABG remains controversial. Hence it is important to identify those patients at high risk for significant carotid disease and those who have vulnerable plaque that is likely to rupture to aid decision making. The aim of this study was to explore whether there is a difference in the degree of MR defined inflammation using USPIO particles, between truly asymptomatic carotid atheromatous plaque in coronary artery disease (CAD) free controls and asymptomatic carotid atheroma found in patients scheduled to undergo CABG. The hypothesis is that inflammatory atheroma is a systemic disease and that one inflamed symptomatic vascular bed (coronary) is likely to increase the risk of other arterial vessels to become inflamed (carotid territory). Although both groups of patients would be classified as asymptomatic from the standpoint of their carotid stenosis, USPIO-enhanced MRI may allow improved risk stratification of the subgroup of asymptomatic patients who harbour vulnerable plaque and who are likely to be at increased risk of developing stroke. Patients & Methods Subjects 10 patients found to have a significant carotid artery stenosis on duplex ultrasound criteria during pre-assessment for CABG surgery were recruited from a specialist neurovascular clinic in a tertiary referral centre. Indications for CABG were poorly controlled angina and congestive heart failure. They were all asymptomatic from their carotid stenosis and therefore had not experienced either a retinal or cortical transient ischaemic attack or a completed hemispheric stroke within the previous 6 months in the designated carotid artery territory. 10 truly asymptomatic individuals with no documented coronary artery disease (CAD) had no neurovascular symptoms before imaging and were used as a control group (CAD-free controls). Documentation of CAD status was done not only by direct questioning of the patient but also case notes review. This group of patients was detected as part of screening tests performed when cervical bruits were picked up by physical examination and as an association with other vascular risk factors such as hypercholesterolaemia, diabetes, peripheral vascular disease and smoking but no documented CAD. Baseline demographic characteristics were collected prospectively ( Table 1 ). The conduct of the MR studies did not cause a delay in planned surgical intervention. Combined CABG and CEA surgery is not routinely performed at our institution. It should also be noted that routine carotid duplex ultrasound screening before CABG is also not performed by all surgeons and hence this sample population is a non-randomised partially selected group that may bias the outcome assessment to a degree. This study was approved by the local ethics committee and all patients gave written informed consent. Patients were included if they had a stenosis ≥ 50% on duplex imaging. Exclusion criteria were 1) prior carotid endarterectomy; 2) prior neck irradiation and 3) contraindications to MRI. High resolution multi-sequence MR imaging Multi contrast imaging of both internal carotid arteries was acquired before and 36 hours after USPIO infusion, using a 1.5T MRI system (Signa HDx, GE Healthcare Technologies, Milwaukee, WI) and a 4-channel phased array neck coil (PACC, Machnet BV, Elde, The Netherlands). Movement artefact was minimised using a dedicated vacuum – based head restraint system (VAC-LOK Cushion, Oncology Systems Limited, UK) to fix the head and neck in a comfortable position and allow close apposition of the surface coils. The imaging protocol has been previously described in detail 6 and included ECG-gated, black blood (BB), fast spin-echo sequences with imaging parameters modified to yield T 1 -weighted and intermediate and heavily T 2 -weighted images for characterising plaque structure. A T 2 *-weighted gradient – echo based spiral sequence with a quadruple inversion recovery preparation was utilised to null the signal from blood pre- and post USPIO. Quantitative image analysis Pre- and post USPIO MR images were manually co-registered according to plaque morphology and distance from the carotid bifurcation at the time of imaging. Images were manually segmented into quadrants using pre-defined rules and the luminal blood pool was excluded from the analysis, (CMR Tools, London, UK). The segmentation protocol was designed to minimise inter-observer error. Signal intensities in each quadrant were normalised to the adjacent sternocleidomastoid muscle pre- and post USPIO. Each quadrant was manually delineated as a region of interest (ROI) and mean signal pre and post-USPIO infusion was calculated ( Fig. 2 ). Positive USPIO – enhanced MRI of carotid plaque was defined arbitrarily as a signal decrease of more than or equal to 10% in 2 or more quadrants between pre and 36 hours post – USPIO imaging. This was determined by two experienced independent readers (TT & SPSH) and confirmed by a consultant neuroradiologist (JHG) who were blinded to the patient's group and their demographics at the time of analysis. Carotid wall area was calculated as the difference between total vessel area and lumen area. The normalised wall index (NWI) was calculated by dividing the wall area by the total vessel area. Statistical Methods Subject characteristics including demographic information and risk factors for atherosclerotic disease were compared between groups. Fisher's exact test was used for frequency counts, and unequal variance t-test for continuous measurements. A statistical model has been previously developed which explicitly models the correlation between signal loss in different quadrants within a slice, and different slices within a plaque and also accounts for any dependence or correlation between multiple measurements made on a single patient. 5 Furthermore, this model allowed quantification of the mean signal change and provided a method for testing for differences between groups and controlling the type-I error rate. A simple summary statistic at the patient level would achieve the necessary independence of data points, but would not provide the same understanding of the inherent structure of the data. USPIO-enhanced MRI signal change was analysed using a repeated measures model with USPIO-enhanced MRI signal change as the outcome variable. The group in question (CABG carotid/truly asymptomatic) was fitted as a fixed effect and patient as a random effect. No other covariates were considered. Slice and quadrant were used to define the within-patient correlation within each side. Estimates of signal change within each side were calculated with appropriate 95% confidence intervals adjusting for the correlation between measurements made on the same subject. An estimate of the difference between sides with appropriate 95% confidence interval was also calculated, together with a p -value testing the hypothesis of no difference between sides. Model assumptions regarding homogeneity of variance were verified by inspection of residual plots. Distributional assumptions regarding normality were verified by assessment of normal probability plots. The analysis was carried out using PROC MIXED in SAS for Windows version 8.2 (SAS Institute, Cary, NC, USA). Results The analysis included 10 asymptomatic patients with severe CAD and awaiting CABG and 10 truly asymptomatic patients with no documented CAD. No patients were excluded because of poor image quality. All patients had risk factors consistent with severe atherosclerotic disease. Patient characteristics are presented in Table 1 . Mean stenosis in the plaques of CABG patients was lower than for those that were completely asymptomatic (59% compared with 65%; p = 0.03), as measured by high resolution axial black blood MR imaging. 7 Patients had between 3 and 9 MRI slices providing sectional images of the carotid plaque. This resulted in a mean of 18.4 quadrants per CABG patient (range 12–36), and 17.6 quadrants per truly asymptomatic patient (range 12–24). One CABG patient had bilateral carotid disease. Both sides from this patient were included for analysis. 94% of all quadrants (173/184) from the CABG group showed USPIO signal loss (range 87.5%–100% within CABG patients), while only 24% (43/176) of quadrants from the truly asymptomatic group showed signal loss (range 0%–45%). A significantly larger proportion of quadrants showed signal loss in the CABG group compared to the truly asymptomatic population ( p < 0.001) (see Fig. 3 ). According to the repeated measures model described earlier, the carotid plaques from the CABG patients showed a significant mean signal intensity decrease of 16.4% after USPIO infusion (95% CI 10.6% to 22.2%; p < 0.001). The truly asymptomatic plaques showed a mean signal intensity increase (i.e. enhancement) after USPIO infusion of 8.4% (95% CI 2.6% to 14.2%; p = 0.007). The difference in signal intensity change between the two groups was 24.9% (95% CI 16.7% to 33.0%; p < 0.001) (see Fig. 4 ). Discussion USPIO-enhanced MRI imaging is a promising non-invasive method to identify high-risk atheromatous plaque inflammation in humans, in which areas of focal signal loss on MR imaging have been shown to correspond to accumulation of iron particles in ex vivo specimens 2,4 USPIO is thought to accumulate predominantly in activated macrophages and signal loss on T 2 * weighted imaging as a result of USPIO uptake, may be considered to be a surrogate measure of the extent of inflammation within the plaque. 1,5 The thrust of this study was to explore whether or not there was a difference in the degree of MR defined inflammation between asymptomatic plaques in patients awaiting CABG and those in individuals with a carotid stenosis who were completely asymptomatic in all vascular territories. The primary findings were as follows: 1. Patients awaiting CABG had more inflammatory activity within their carotid atheroma than did the completely asymptomatic cohort as demonstrated by normalized signal loss in significantly more quadrants and a significant mean signal intensity decrease after USPIO infusion, despite a mean lower degree of luminal stenosis (59% versus 65%). 2. Completely asymptomatic individuals had significantly more quadrants with signal enhancement, possibly implying a larger fibrous cap component and hence possibly greater plaque stability. However, there was also a subset of quadrants showing signal loss too. The results of this study support previous work that USPIO may be useful in the assessment of inflammatory activity in asymptomatic carotid atherosclerotic plaques. 6 We have previously shown that almost 100% of symptomatic carotid plaques demonstrated USPIO uptake in contrast with decreased uptake in any asymptomatic contralateral lesions. 5 In turn, the contralateral side to the symptomatic stenosis showed more USPIO enhanced MR defined inflammation than the truly asymptomatic plaques. 6 These findings are consistent with the hypothesis that inflammatory atheroma is a systemic disease and suggests that one inflamed symptomatic vascular bed is likely to increase the likelihood that other arterial vessels to become or are inflamed. Furthermore, the results suggest that the carotid territory is more likely to take up USPIO if another vascular territory is symptomatic. Biochemical and histopathological studies have found that active inflammation in acute coronary syndrome is not confined to the “culprit” coronary plaque but is part of a widespread activation of the coronary tree. 8,9 Other clinical studies have suggested that a status of panvascular active inflammation exists. 10,11 Furthermore, plaque instability may not be confined to a single “culprit” lesion nor be within only one vascular territory. A higher frequency of complex carotid plaques as detected by ultrasonography were found in patients with unstable angina and increased C-reactive protein levels. 12 Signs of carotid plaque instability on MR imaging have been also associated with clinical symptoms. 13 Furthermore, the results point at the possibility for a more accelerated disease progress that could partly explain the difference in prognosis of a culprit lesion if part of a more widespread phenomenon versus being a solitary manifestation. Evidence for this has been present for some time – the prognosis of non-invasively assessed atherosclerotic carotid stenosis, peripheral artery disease and ischaemic heart disease are likely to be dependent on the concomitant disease burden. 14 In the present study, inflammation as defined by signal loss on USPIO enhanced MR imaging was more frequently observed in patients with active CAD. This was also reflected in the difference in CRP levels between the two groups. Systemic activation of the inflammatory system might be a pathological process linking both coronary and carotid plaque vulnerability. However this hypothesis can only be validated following large scale prospective natural history studies. Unfortunately at the time of writing no such studies exist and therefore although this study represents interesting preliminary work, it requires validation not only in terms of a larger number of patients but also corroborative natural history data. Were such validation to be possible, there might be a strong argument in the future for following a group of CABG patients prospectively in a future USPIO study to determine the number of cerebrovascular events that occur peri-operatively. An interesting question is whether or not there is a correlation between the degree of USPIO uptake pre-operatively and the development of stroke subsequently – only a large longitudinal study would likewise be able to answer this question. This is highly clinically relevant as patients awaiting coronary revascularisation who are found to have a degree of carotid artery stenosis may still be offered CEA prior to CABG. It remains unclear whether this is clinically appropriate or whether a synchronous procedure is indicated. At first glance, statistical analysis of the patient characteristic data reveals a significant difference between the degree of stenosis between the CABG and truly asymptomatic groups (59% versus 65% respectively). Thus it should naturally follow that the higher the stenosis the greater the inflammation and therefore the higher the risk. This in fact was not the case since the group with the least amount of stenosis (i.e. CABG group) had the highest degree of USPIO – defined inflammation, quite contrary to intuitive and conventional expectations. This was also seen in a previous USPIO study imaging asymptomatic carotid disease, whereby USPIO attributable signal loss was found to be greater in the asymptomatic plaques contralateral to the symptomatic stenosis than in the completely asymptomatic ones, despite the fact that the atheroma on the contralateral side had a significantly lower degree of stenosis than the truly asymptomatic cohort. 6 Thus, USPIO uptake may be a factor able to enhance risk stratification when compared with luminal stenosis alone. Study limitations Limitations of the study include, by design, that there was no corroborative evidence from histology although Trivedi et al. have shown that there is good correlation and co-localisation of USPIO uptake on MRI and USPIO staining of activated macrophages within carotid plaque. 2 Quantification of macrophage burden by USPIO signal change remains unclear and the technique described in this study in quantifying signal change is by no means definitive as numbers who have had USPIO infusions are still small. Little is known of the natural history of USPIO uptake in asymptomatic atheroma. A longitudinal study may help answer whether inflammatory burden alters over time or whether large USPIO uptake can indeed be eventually correlated with patient ischaemic events. Another shortcoming of the study is that the sample size used is too small to make any statements suggesting similarity of the two groups because of the risk of a type II statistical error. Also there is no formal documentation of the extent of coronary artery disease burden in terms of angiographic investigations or stress evaluations of the truly asymptomatic individuals. However, we would not have been able to clinically or ethically justify this. Conclusions Asymptomatic carotid plaques in patients awaiting CABG seem to demonstrate more inflammation than those of truly asymptomatic individuals. Inflammatory activity may be a significant risk factor in asymptomatic disease and may help risk stratify this patient cohort in the future. Stroke is just one of the many silos of a larger vascular problem. Earlier and more refined global vascular risk estimation should lead to advances in our understanding of ways to modify risk. MR imaging of the carotid artery may serve as a window to image the entire cardiovascular system and be able to identify “vulnerable” plaques and patients who are at high risk of developing future coronary and cerebrovascular events. Acknowledgments The authors wish to thank M E Gaunt and J R Boyle for contributing their patients to the study, the MR radiographers, Ilse Joubert and Ruth Beavon for their hard work and Tim Baynes, Specialist Research Nurse, for his dedication and support. References 1 R. Ross Atherosclerosis – an inflammatory disease N Engl J Med 340 2 1999 115 126 2 R.A. Trivedi C. Mallawarachi J.M. U-King-Im M.J. Graves J. Horsley M.J. Goddard Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages Arterioscler Thromb Vasc Biol 26 7 2006 1601 1606 3 R.A. Trivedi J.M. U-King-Im M.J. Graves P.J. Kirkpatrick J.H. Gillard Noninvasive imaging of carotid plaque inflammation Neurology 63 1 2004 187 188 4 R.A. Trivedi J.M. U-King-Im M.J. Graves J.J. Cross J. Horsley M.J. Goddard In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI Stroke 35 7 2004 1631 1635 5 T. Tang S.P. Howarth S.R. Miller R. Trivedi M.J. Graves J.U. King-Im Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI Stroke 37 9 2006 2266 2270 6 T.Y. Tang S.P. Howarth S.R. Miller M.J. Graves J.M. UK-I R.A. Trivedi Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study J Neurol Neurosurg Psychiatry 2007 7 J.M. U-King-Im R.A. Trivedi E. Sala M.J. Graves M. Gaskarth N.J. Higgins Evaluation of carotid stenosis with axial high-resolution black-blood MR imaging Eur Radiol 14 7 2004 1154 1161 8 A. Buffon L.M. Biasucci G. Liuzzo G. D'Onofrio F. Crea A. Maseri Widespread coronary inflammation in unstable angina N Engl J Med 347 1 2002 5 12 9 L.G. Spagnoli E. Bonanno A. Mauriello G. Palmieri A. Partenzi G. Sangiorgi Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction J Am Coll Cardiol 40 9 2002 1579 1588 10 R.D. Henderson M. Eliasziw A.J. Fox P.M. Rothwell H.J. Barnett Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group Stroke 31 1 2000 128 132 11 A. Cohen C. Tzourio B. Bertrand C. Chauvel M.G. Bousser P. Amarenco Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke Circulation 96 11 1997 3838 3841 12 A. Lombardo L.M. Biasucci G.A. Lanza S. Coli P. Silvestri D. Cianflone Inflammation as a possible link between coronary and carotid plaque instability Circulation 109 25 2004 3158 3163 13 T. Saam C. Yuan B. Chu N. Takaya H. Underhill J. Cai Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging Atherosclerosis 2006 14 M. Ogren B. Hedblad S.O. Isacsson L. Janzon G. Jungquist S.E. Lindell Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis Lancet 342 1993 1138 1141